Hi, what are you looking for?
Jewish Business News
Search results for "RedHill "
Health New Researches
Opaganib manufacturing is to be expanded with two Canadian and European firms.
Business
RedHill Biopharma Ltd. today announced positive results in its trial of its product RHB-104 for the treatment of Crohn’s Disease. RedHill’s share price surging up 67%...
Business
RedHill Biopharma Ltd., an Israeli biopharmaceutical company today announced a research collaboration with Leipzig-based Fraunhofer Institute for Cell Therapy and Immunology (IZI), a research unit...
Business
– The University of Minnesota is buying rights for the development of a diagnostic Crohn’s disease test. Israeli RedHill Biopharma Ltd. (Nasdaq:RDHL) (TASE:RDHL) ,...
Business
– Mesupron, which targets gastrointestinal and other cancers, has been licensed from Wilex. RedHill Biopharma Ltd. (Nasdaq: RDHL); TASE: RDHL) has expanded its late clinical-stage gastrointestinal-focused pipeline...
Business
RedHill Biopharma Ltd.(NASDAQ: RDHL; TASE: RDHL) , today announced preliminary positive data from a pre-clinical study with RHB-104 for the treatment of type 1...
Business
– RedHill Biopharma and Salix Pharmaceuticals Announce Worldwide Exclusive License Agreement for RedHill’s RHB-106 Encapsulated Bowel Preparation. Salix Pharmaceuticals Ltd. (NASDAQ: SLXP) and RedHill Biopharma...
VC, Investments
– Press release TEL-AVIV, Israel, January 14, 2014, RedHill Biopharma Ltd. (NASDAQ: RDHL; TASE: RDHL) (the “Company” or “RedHill”), an emerging Israeli biopharmaceutical company...
VC, Investments
– RedHill Biopharma Ltd. (Nasdaq: RDHL; TASE: RDHL), today announced that it has entered into a definitive agreement with leading healthcare investor OrbiMed Israel Partners...
Business
– RedHill Biopharma Ltd. (Redhill) reported positive pharmacokinetic (PK) clinical studies for their planned new drug application (NDA) for their RHB-102 extended release Anti-Emetic product. RedHill is an emerging Israeli...